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Introduction:  Cemented  versions  of dual-mobility  cups  (DMCs),  helpful  in  cases  of bone  stock  alteration,
are  usually  used  in  association  with a reinforcement  device.  To  simplify  the  intervention  in  elderly  sub-
jects  or  those  with  a poor  bone  stock,  the  cups  can  be  cemented  directly  into  the  bone,  but the  long-term
result  remains  uncertain.  We  conducted  a retrospective  study  in  this  population  so as to:  (1)  assess
whether  cemented  ﬁxation  of a DMC  without  a  reinforcement  device  leads to  a higher  loosening  rate,  (2)
conﬁrm  its efﬁcacy  in preventing  dislocations  in  subjects  at high  risk  of instability,  and  (3) measure  the
functional  results.
Hypothesis:  Cemented  ﬁxation  of a DMC is reliable  in cases  of  moderate  alteration  of  bone  stock.
Material  and  methods:  Sixty-four  patients  (66 hips)  undergoing  implantation  of a cemented  DMC
(SaturneTM) without  a reinforcement  device  were  included  in  this  single-center  retrospective  study.  Their
mean  age  was  79.8  years  (range,  40–95  years).  The  indications  varied:  hip  osteoarthritis  (30.3%),  pros-
thesis  revision  (44.0%),  and  trauma  (25.8%).  The  patients  were  evaluated  radiologically  and  clinically  at
follow-up.  The  main  evaluation  criterion  was the  revision  rate  for  aseptic  loosening.  Dislocations,  the
infection  rate, and  the Postel  Merle  d’Aubigné  (PMA)  score  were  noted.
Results:  At  the  mean  follow-up  of  4.2  years,  three  (4.6%)  patients  had  been  lost  to  follow-up  and  22
(33.3%)  had died.  There was  one  case  of  aseptic  loosening  (1.5%).  Cup  survival  was  98% at 5  years  (95%CI
[94–100]).  There  were  no  dislocations.  There  was  one  revision  for  infection.  The  mean  PMA  score  was
15.5  (range,  9–18).
Discussion: The  frequency  of acetabular  loosening  was  comparable  to the frequency  in cemented  DMCs
with  a reinforcement  device.  A cemented  DMC  without  a  reinforcement  device  is  possible  and  is  a  simple
and  viable option  when  there  is  moderate  bone  stock  alteration.
Level  of evidence:  IV,  retrospective  cohort  study.
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Dislocation following total hip arthroplasty (THA) has major
unctional, psychological, and economic consequences [1]. Dual
obility cups (DMCs), available since 1976 [2], have proven their
fﬁcacy in preventing dislocations [3], without an increase in the
ear rate [2,4] or the loosening rate based on several recent studies
n cementless DMCs [5,6].
The use of DMCs in a cemented version is sometimes nec-
ssary because of poor bone stock. For example, when there is
∗ Corresponding author. Tel.: +33 1 47 10 77 27; fax: +33 1 47 10 77 03.
E-mail address: tx haen@outlook.com (T.X. Haen).
http://dx.doi.org/10.1016/j.otsr.2015.09.027
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.insufﬁcient primary ﬁxation with a cementless cup, some authors
recommend using a cemented implant rather than increasing the
reaming diameter [7] (increased alteration of bone stock, risk of
psoas-iliac muscle irritation). Cemented DMCs were initially used
in association with cup reinforcement, but the implantation of rein-
forcement devices poses a neurovascular risk and lengthens the
duration of surgery [3,8,9]. Implantation without an acetabular
reinforcement device has been described more recently [10–13]
(in case of THA revision with moderate alteration of bone stock or
failure of impaction with a press-ﬁt cup), but the medium-term
results with a large cohort have not been described. Moreover,
some authors currently advise against this procedure, fearing an
increased risk of acetabular loosening [14–16]. Since the outcome of
DMCs cemented directly in fragile bone or with moderate alteration
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Table 1
Preoperative epidemiological data.
Mean age 79.8 ± 11.1 years (range, 40–95 years)
Mean body mass index 24.3 kg/m2
ASA score Mean, 2.3 ± 0.7
ASA 1: 4 (6.1%)
ASA 2: 41 (62.1%)
ASA 3: 19 (28.8%)
ASA 4: 1 (1.5%)
ASA 5: 1 (1.5%)
Gender 48 females (72.7%)
18 males (27.3%)
Risk factors for dislocation (RF) 1.6 per patient on average ± 0.8
0  RF: 6 (9.1%)
1 RF: 21 (31.8%)
2 RF: 31 (47.0%)
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(numeric evaluation [NE], between 0 and 10) were also noted.
Only patients who  had radiological follow-up more than 1 year
after surgery underwent the ﬁnal radiographic analysis, i.e., 42 hips
Table 3
Surgical data.
n %3 RF: 8 (12.1%)
SA: American Society of Anesthesiologists.
f the bone stock remains imprecise, we conducted a retrospective
tudy to: (1) assess whether cemented ﬁxation of a DMC  without
 reinforcement device leads to a higher loosening rate, (2) con-
rm its efﬁcacy in preventing dislocations in subjects at high risk
f instability, and (3) measure the functional results of a cemented
MC. We  hypothesized that cemented ﬁxation of a DMC  is reliable
n patients with moderate alteration of bone stock.
. Material and methods
.1. Patients
We  conducted a single-center retrospective study on consec-
tive patients who had undergone a THA with a cemented DMC
ithout a reinforcement device between January 2005 and May
011. Only patients whose follow-up was longer than 1 year were
ncluded. Sixty-four patients (66 hips) were included. The epi-
emiological data are indicated in Table 1. The patients’ mean age
as 79.8 ± 11.1 years (range, 40–95 years). Sixty patients (90.9%)
ad at least one risk factor for dislocation: American Society of
nesthesiologists (ASA) score ≥ 3 [17], age ≥ 80 years [18], arthro-
lasty revision [17], a history of hip instability [3], and a prosthesis
mplanted after fracture of the upper extremity of the femur [19].
he surgical indications are listed in Table 2.
Surgery was performed by a senior surgeon in 37 cases (56.1%).
he approach was posterolateral, with reinsertion of the piriformis
endon. A SaturneTM (Amplitude, Valence, France) (Fig. 1) DMC
as used in its cemented version. The acetabulum was prepared
sing reams of increasing size up to 2 mm greater than the cup
iameter. Three anchorage studs were made. The cement was high-
iscosity Palacos GentallineTM® (Heraeus, Werheim, Germany). The
TMemoral stem was an Exaﬁt (Zimmer, Winterthur, Switzerland)
tem, with a thin femoral neck designed to minimize the contacts
ith the polyethylene insert [3]. A 28-mm-diameter head was used
xcept with small-diameter cups (44 or 46 mm),  which required a
able 2
nitial surgical indications.
Indication n %
Hip osteoarthritis with osteoporotic
bone
20 30.3
Revision for dislocating prosthesisa 19 28.8
Fracture of femoral neck 12 18.2
Revision for acetabular loosening 10 15.2
Migration of osteosynthesis material
after ﬁxation of proximal femoral
fracture
5 7.6
Total 66 100.0
a Including two cases of bipolar prothesis revision.Fig. 1. SaturneTM cement implant: metal-back in stainless steel with grit-blasted
coating; anterior notch (preventing impingement with psoas tendon).
22.2-mm head. The indications for ceramic heads were hip
osteoarthritis before the age of 75 years. The surgical data are
detailed in Table 3. In case of prosthesis revision, the possibility of
using an isolated cemented DMC  was  conﬁrmed intraoperatively, if
bone substance loss did not exceed stage IIc in the Paprosky classi-
ﬁcation [20]. Fig. 2 shows an example of revision due to loosening.
2.2. Evaluation methods
The patients underwent radiological and clinical follow-up at
3 months, 1 year, and then every 2 years. They were asked to
attend another visit if the last follow-up visit had been more than 3
months before. The main evaluation criterion was the revision rate
for aseptic loosening. Occurrence of dislocation, the infection rate,
the Postel Merle d’Aubigné (PMA) functional score [21], and painSide Right: 38 57.60
Left: 28 42.40
Cup size (mm)
44 3 4.50
46  3 4.50
48  12 18.20
50  17 25.80
52  13 19.70
54  5 7.60
56  9 13.60
58  3 4.50
60  1 1.50
Prosthesis head size (mm)
22.2 9 13.60
28  57 86.40
Prosthesis head material
Chrome-cobalt 40 60.60
Alumina 26 39.40
Morselized bone graft Autograft: 1 1.50
Allograft: 2 3.00
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lig. 2. Example of revision with a dual-mobility cup for aseptic loosening. A. Pre-
perative. B. At 4-year follow-up.
63.6%). The radiolucent lines (DeLee and Charnley zones [22]) were
tudied. The appearance of a continuous radiolucent line wider
han 2 mm or cup migration greater than 3 mm was  interpreted
s radiological loosening [3]. The cup inclination was  measured.
.3. Statistical analysis
A descriptive analysis of all the data collected was  performed.
he continuous variables were expressed as means ± standard
eviation (range) and the categorical variables were expressed as
requencies (percentages). For the dual-mobility cup survival anal-
sis, a Kaplan-Meier curve was calculated with a 95% conﬁdence
nterval. The endpoint was revision due to a mechanical cause. A
ilcoxon test was used to study the repercussions of a radiolucent
ine on the PMA score and the NE of pain. The signiﬁcance thresholdFig. 3. 5-year survival curve (failure: revision for mechanical cause).
was set at P < 0.05. Given the low rate of missing data (<5%), the
analysis was  performed only on complete data using R software (v
10.13/R Development Core Team, http://www.r-project.org/).
3. Results
For the 66 DCMs included in the study, the mean clinical follow-
up was  4.2 years ± 1.9 (range, 1–8.2). Three patients were lost to
follow-up (4.6%). Twenty-two patients (33.3%), with a mean age of
82.4 years ± 1.6 (range, 51–94 years) at the time of surgery, had
died (of causes independent of the intervention), on average 2.9
years ± 1.7 (range, 1.1–6.3 years) after the surgery.
Of the 66 cups implanted, there was one revision for aseptic
loosening (1.5%), in an 82-year-old female patient, 3 years after a
cemented DMC  revision for repeated loosening, with no reinforce-
ment device despite an associated acetabulum fracture.
According to the Kaplan-Meier method, the cup survival rate
was 98% at 5 years (95% CI [94–100]), taking revision for loosening
as the endpoint (Fig. 3).
There were no dislocations at the mean follow-up of 4.2 years.
There was  one postoperative deep infection that required revision
(1.5%) in an ASA 3 patient. Assessment at the last follow-up showed
a mean NE score at 7/10 ± 1.3 (range, 0–7) and a mean PMA  score
at 15.5 ± 1.9 (range, 9–18).
The radiographic analysis on only the cohort that had radio-
graphic follow-up longer than 1 year (42 patients) was  done at
3.0 ± 1.9 years (range, 1–8 years). Two  patients (4.8%) had radi-
olucent lines immediately after surgery, which did not progress.
Radiolucent lines, affecting two  DeLee zones out of three, mea-
suring a mean 1.3 mm thick (range, 1–2 mm),  appeared in three
patients (7.1%) after a mean 3.3 years (range, 3–4 years). The pres-
ence of radiolucent lines did not result in statistically signiﬁcantly
different clinical results (PMA and NE scores). There was one case
of cup migration as described above and no additional loosening.
The mean cup inclination was  45.3 ± 5.7◦ (range, 35–56◦).
4. Discussion
Use of DMCs in their cemented version without reinforcement
has encountered controversy [10–14], with certain authors fearing
an increased risk of loosening. At a mean follow-up of 4.2 years,
the present study found only one case of revision for aseptic loos-
ening (cup survival, 98% at 5 years). The only case of loosening was
related to an erroneous surgical indication: acetabular reinforce-
ment should have been selected given the context of acetabulum
926
 
T.X
.
 H
aen
 et
 al.
 /
 O
rthopaedics
 &
 Traum
atology:
 Surgery
 &
 R
esearch
 101
 (2015)
 923–927
Table 4
Cemented dual mobility cups, literature review.
Study Number of
subjects
Mean age
(years)
Indication(s) Implant(s) Fixation Mean follow-up
(years)
Death (%) Lost to
follow-up (%)
Dislocation (%) Intraprosthetic
dislocation (%)
Revision for
loosening (%)
Simian et al. [23] 74 67.9 Revision for all
causes
DMSTM (64%),
EvoraTM (31.1%),
MobilitéTM (5.4%)
Cemented: 63.5%
(reinforcement:
31,1%; without:
32.4%)
7.3 14.1 2.8 1.4 0.0 1.4
Van  Heumen et al. [13] 50 67 Revision for
instability
AvantageTM Cemented without
reinforcement: 92%
Uncemented: 8%
2.4 4.0 0.0 0.0 0.0 2.0
Mukka  et al. [12] 34 75.7 38.2% fracture of
femoral neck
35.3% revision
26.5% hip
osteoarthritis
AvantageTM Cemented, no
reinforcement
1.5 nc nc 6.0 0.0 0
Hailer  et al. [10] 228 nc Revision for
instability
AvantageTM Cemented: 82%
(5% in AR)
2 nc nc 2.0 0.0 1.80
Tarasevicius et al. [11] 42 75 Fracture of femoral
neck
AvantageTM Cemented, no
reinforcement
1 23.5 0.0 0.0 0.0 0
Civinini  et al. [9] 33 69 Revision for
loosening
AvantageTM (72.7%) Cemented in AR 3.3 0.0 0.0 0.0 0.0 0
Pattyn  et al. [24] 37 70.4 Revision (loosening
54%)
ApogeeTM Cemented in AR 1.3 0.0 0.0 5.4 0.0 0
Schneider  et al. [8] 96 69.9 Revision (loosening
80.2%)
Novae-StickTM Cemented in AR 3.4 15.6 4.2 10.4 0.0 1
Philippeau et al. [25] 71 54.1 Tumor
involvement in
acetabulum
Multiple Cemented in AR:
57.7%, otherwise
uncemented
2.2 47.9 9.9 9.8 0.0 8.40
Hamadouche et al. [3] 51 71.4 Revision for
instability
Medial CupTM Cemented (in AR:
43.1%)
4.3 3.9 3.9 2.2 2.2 1.96
Our  series 66 79.8 Multiple SaturneTM Cemented, no
reinforcement
4.2 33.3 4.6 0.0 0.0 1.5
AR: acetabular reinforcement.
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design use in preventing total hip replacement dislocation following tumor
resection. Orthop Traumatol Surg Res 2010;96:2–8.T.X. Haen et al. / Orthopaedics & Traumat
racture. We  observed asymptomatic radiolucent lines in 7.1% of the
ases, a rate that is in line with the literature [23]. In our study the
oosening rate was 1.5%, which is comparable to cemented DMCs
n a reinforcement device [3,8,9,24,25] (Table 4) and much lower
han the high loosening rates at the intermediate term described
or retentive cups (up to 8.3% at 3 years [26]).
Several limitations to this study should be discussed. Follow-up
as limited to 4.2 years, which does not make it possible to con-
lude on implant stability over the longer term. This can be partially
xplained by the high number of deaths (33.3%), which is inherent
o the characteristics of the study population (mean age, 79.8 years;
ean ASA score, 2.3). Yet cemented DMCs can be particularly useful
n this type of population. Moreover, this length of follow-up is suf-
cient to conﬁrm the efﬁcacy in preventing dislocations, since the
ajority of dislocations occur in the ﬁrst 3 months after implanta-
ion [19]. We  also conﬁrmed the good functional results of DMCs,
espite 43.9% of the interventions having been performed by junior
urgeons (a frequent situation in the hospital context).
The sample size was relatively small (66 hips), but to our knowl-
dge this was one of the largest series investigating cemented DMCs
xclusively (Table 4). The study reported by Hailer et al. [10], includ-
ng 228 cemented DMCs, showed good results, but the median
ollow-up was limited to 2 years. Even though the population in
he present study was older (5–10 years older on average), the
esults were comparable. Like the majority of studies published on
MCs, this study was retrospective, there was  no control group,
nd the clinical assessment was rarely carried out by an indepen-
ent observer. However, the consequences of this retrospective
esign were limited: the results of standard cups are well known
n this context [8] and the main evaluation criterion (revision due
o loosening) is relatively robust.
Prosthesis revisions made up 44% of the indications in our study.
herefore we believe that a cemented DMC  can be used when there
s bone stock alteration up to stage IIc in the Paprosky classiﬁcation
20], adding a bone graft in certain situations (stages IIb and IIc).
. Conclusion
DMCs are recommended in patients at risk for dislocation or
n patients older than 70 years [5,7]. Cemented DMCs without a
einforcement device do not induce an increased risk of loosen-
ng at the intermediate term and present similar results to the
atest-generation impacted DMCs. These implants can be used in
ituations in which poor bone stock makes use of an impacted
mplant impossible and use of acetabular reinforcement is not nec-
ssarily indispensable.
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